MOTS-C is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MOTS-C is one of the most discussed peptides in the research community, with reports focusing on its effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility. First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
What Do Researchers Report About MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is one of the most discussed Mitochondrial-derived peptide, metabolic regulator compounds in the peptide research community. Reports span effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
What Are the Most Common Positive Reports?
Researchers frequently cite MOTS-C's effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility as the primary benefits observed during standard cycles of 8-12 weeks with 8-12 week breaks.
The first mitochondrial genome-encoded peptide to enter human testing — essentially exercise in a peptide, activating the same AMPK pathways triggered by physical training. This distinctive profile is a key reason MOTS-C maintains its popularity despite the growing number of alternatives.
What Are the Common Criticisms?
The most common complaints about MOTS-C: Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Cost and sourcing quality are also frequent concerns — results vary significantly between vendors, which is why COA testing is essential.
How Does MOTS-C Compare to Alternatives?
As a Mitochondrial-derived peptide, metabolic regulator, MOTS-C competes with several similar compounds. The first mitochondrial genome-encoded peptide to enter human testing — essentially exercise in a peptide, activating the same AMPK pathways triggered by physical training.
Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization.
Bottom Line: Is MOTS-C Worth It?
Based on the available research and community reports, MOTS-C is well-regarded for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility. The key factors for success: consistent dosing (5-10 mg per week 2-3 times weekly), quality sourcing, and realistic expectations over 8-12 weeks with 8-12 week breaks cycles.
Complete Guide
MOTS-c: The Metabolic Mitochondrial Peptide
Related Reading
- MOTS-C Dosage Guide
- MOTS-C Benefits
- MOTS-C Side Effects
- MOTS-C Stacking Guide
- MOTS-C Cycle Guide
- MOTS-C Research
Calculate Your MOTS-C Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MOTS-C.
Open Calculator →Research-Grade Sourcing
If you're going to research MOTS-C, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging. It is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
What is the recommended MOTS-C dosage?
Common dosages: 5-10 mg per week administered 2-3 times weekly via subcutaneous injection. Cycle length: 8-12 weeks with 8-12 week breaks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of MOTS-C?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Is MOTS-C safe?
MOTS-C has shown a favorable safety profile in research. Not FDA-approved. Listed by FDA as unlawful for compounding. Available as research chemical only. All research should follow appropriate safety protocols.